Cargando…
Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk
Autores principales: | Velez, Gabriel, Nguyen, Huy V., Chemudupati, Teja, Ludwig, Cassie A., Toral, Marcus, Reddy, Sunil, Mruthyunjaya, Prithvi, Mahajan, Vinit B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903662/ https://www.ncbi.nlm.nih.gov/pubmed/33627107 http://dx.doi.org/10.1186/s12943-021-01336-4 |
Ejemplares similares
-
Cross-Platform Identification and Validation of Uveal Melanoma Vitreous Protein Biomarkers
por: Velez, Gabriel, et al.
Publicado: (2023) -
“Giant cell arteritis manifesting as retinal arterial occlusion and paracentral acute middle maculopathy in a patient on pembrolizumab for metastatic uveal melanoma”
por: Narala, Ramsudha, et al.
Publicado: (2020) -
Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma
por: de Bruyn, Daniël P., et al.
Publicado: (2022) -
Potential of Aqueous Humor as a Liquid Biopsy for Uveal Melanoma
por: Im, Deborah H., et al.
Publicado: (2022) -
Proteomic analysis of intermediate uveitis suggests myeloid cell recruitment and implicates IL-23 as a therapeutic target
por: Sepah, Yasir J., et al.
Publicado: (2020)